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Abstract
Background: Animal models of human behavioral endophenotypes, such as the Tail Suspension Test (TST) and the Open
Field assay (OF), have proven to be essential tools in revealing the genetics and mechanisms of psychiatric diseases. As in
the human disorders they model, the measurements generated in these behavioral assays are significantly impacted by the
genetic background of the animals tested. In order to better understand the strain-dependent phenotypic variability
endemic to this type of work, and better inform future studies that rely on the data generated by these models, we
phenotyped 33 inbred mouse strains for immobility in the TST, a mouse model of behavioral despair, and for activity in the
OF, a model of general anxiety and locomotor activity.
Results: We identified significant strain-dependent differences in TST immobility, and in thigmotaxis and distance traveled
in the OF. These results were replicable over multiple testing sessions and exhibited high heritability. We exploited the
heritability of these behavioral traits by using in silico haplotype-based association mapping to identify candidate genes for
regulating TST behavior. Two significant loci (-logp .7.0, gFWER adjusted p value ,0.05) of approximately 300 kb each on
MMU9 and MMU10 were identified. The MMU10 locus is syntenic to a major human depressive disorder QTL on human
chromosome 12 and contains several genes that are expressed in brain regions associated with behavioral despair.
Conclusions: We report the results of phenotyping a large panel of inbred mouse strains for depression and anxiety-
associated behaviors. These results show significant, heritable strain-specific differences in behavior, and should prove to be
a valuable resource for the behavioral and genetics communities. Additionally, we used haplotype mapping to identify
several loci that may contain genes that regulate behavioral despair.
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Introduction
Major affective disorders, including depression, anxiety, bipolar
disorder, and schizophrenia, have a combined lifetime prevalence
rate of approximately 25% [1]. Psychiatric disorders are also a risk
factor for a host of disorders ranging from substance abuse to heart
disease [2]. Although most forms of psychiatric disease exhibit 40–
60% heritability, very few causative genes have been conclusively
identified [3,4,5]. Several major hurdles have impeded the success
of genome-wide association scans, including genetic heterogeneity,
epistatic gene interactions, and the role that the environment plays
in the development and expression of the disease [6].
The use of model organisms can reduce the impact of
confounding factors on complex phenotypes. In humans, depres-
sion is characterized by a combination of cognitive, emotional, and
physiological symptoms; because it is difficult to model many of
these symptoms in animals, tests generally focus on a single
behavior that represents a specific human endophenotype. Two of
these tests, the Tail Suspension Test (TST) and Forced Swim Test
(FST), measure stress-induced coping mechanisms [7,8]. In both
the TST and FST, an animal is faced with an inescapable stress
(being suspended by the tail or trapped in a beaker of water), and
the immobility that eventually develops is believed to represent a
state of behavioral despair. The validity of these tests as a model
for depression is suggested by a number of factors. First, clinically
effective human treatments such as antidepressants reduce TST
and FST immobility [9,10]; second, manipulation of genes known
to be involved in depression in humans affects TST and FST
performance [11,12,13,14]; and, finally, mice bred to express a
behavioral or physiological ‘‘depressive’’ phenotype show in-
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considered a valid model of anxiety, as it puts an animal in a
stressful situation (an open field) and takes advantage of an
ethologically relevant response (thigmotaxis) to measure general
anxiety [18].
It has previously been observed that inbred mice show strain-
dependent responses to behavioral tasks, indicating that factors
that regulate performance in these tasks are under genetic control
[19]. The common inbred strains have been shown to encompass
phenotypic variation on par with human populations for a number
of complex behavioral and metabolic traits [20,21]. Notably, a
number of inbred mouse strain differences have been documented
for physiological and behavioral phenotypes relevant to human
mood disorders. For example, serotonin levels and serotonin
receptor binding are higher in C57BL/6J mice than in BALB/cJ
[22], while BALB/cJ mice have higher baseline and stress-induced
corticosterone levels than several other strains [23]. Researchers
have also identified strain differences in hippocampal size [24],
serotonin receptor distribution in the brain [25], whole brain
monoamine and catecholamine content [26,27,28], and hippo-
campal neurogenesis [29,30].
Phenotyping of inbred mouse strains offers multiple benefits
[19]. First, because the genetics of these populations are fixed,
each strain only has to be phenotyped once, and the results can be
interrogated repeatedly without requiring additional animals.
Second, knowledge of specific strain characteristics (high versus
low anxiety, drug metabolism, etc.) allows researchers to select the
most appropriate strain for their research. The public availability
of phenotype data in the Jackson Lab’s Mouse Phenotype
Database (http://phenome.jax.org) has been a significant resource
for the community [31]. Finally, the mosaic genetic structure and
phenotypic diversity of inbred strains can be leveraged to identify
biologically important genetic loci for complex traits using
haplotype association mapping (HAM) [32,33]. This methodology
has been successfully used to identify genes that play a role in
acetaminophen-induced liver injury [34], regulation of oxidative
phosphorylation in vivo [35], expression of a family of genes
involved in drug detoxification [36], anxiety [37], bone mineral
density [38], lung tumor susceptibility [39], and drug metabolism
[40]. In each of these cases, work was done to validate that the
genes underlying the significant association peaks directly regulate
the end phenotype. In the case of the acetaminophen-induced
toxicity, the predisposing loci were shown to directly translate to
the human population, meaning that a statistically significant
portion of the susceptible population carried a particular allele of
the same gene implicated in the mouse haplotype association
mapping. While most of these studies were successful in using a
modest number of inbred strains to power their associations, it has
been estimated that a larger set will be required to identify genes
that have smaller effect sizes and reduce false positives [41].
Behavioral traits in particular are expected to be regulated by a
large number of causative genes that each exert a small influence
[6].
In the present study, we selected 33 inbred laboratory mouse
strains, including 31 classical inbred strains and 2 wild-derived
strains, based on the Mouse Phenome Database priority list and
the availability of single nucleotide polymorphism (SNP) data. We
phenotyped almost 800 mice for 3 behavioral traits: behavioral
despair (immobility in the TST), general anxiety (thigmotaxis in
the Open Field), and general motor activity (distance traveled in
the Open Field). In each of these tests, there were clear strain-
specific differences, and we were able to draw correlations between
the degree to which performance on each task influenced
performance on the other behavioral tasks. Finally, we used
strain-specific performance in the TST as a quantitative
phenotype for haplotype mapping and identified two ,300 kb
genetic loci with a lod score .7 (corrected p value ,0.04),
indicating that inbred strain phenotyping and haplotype mapping
can successfully be applied to identify risk loci for complex
phenotypes.
Materials and Methods
Animals
Male mice from 33 inbred strains (Table S1) were obtained
from The Jackson Laboratory (Bar Harbor, ME) at 3–5 weeks of
age. Mice were housed at a density of 3 per cage and maintained
on a 12:12 light:dark cycle (lights on =0700 h). Food and water
were available ad libitum. Mice were allowed to acclimate for 1
month prior to behavioral testing. All animal procedures were
approved by the Scripps Florida Institutional Animal Care and
Use Committee under protocol 06-019.
Behavioral testing
Behavioral testing took place between 1300 h and 1600 h in a
room separate from the colony room. Mice were brought into the
behavioral testing room immediately prior to testing and removed
immediately afterward, and the behavioral apparatus was cleaned
with a disinfectant between each mouse. Four to eight mice were
tested at a time, and strains were randomized across day, time of
testing, and equipment. Each individual was only tested once in
each task.
Tail Suspension was performed using a Mouse Tail Suspension
setup (Med Associates, Georgia, VT). In this test, the mouse is
placed inside a 3-sided cubicle and suspended by its tail from a
hanger attached to a precision linear load cell that measures
activity. Measurements were taken in 200ms increments for 7
minutes, with threshold =3 and gain =8. Because all mice were
uniformly active for the first minute, percent immobility was
calculated by determining the time spent immobile during the last
6 minutes of the test. Mice that climbed their tail or fell off the
hanger were excluded from analysis. A total of 780 mice were
successfully phenotyped in the TST.
One week later, mice were tested in a Med Associates mouse
Open Field contained within an environmental chamber that
provided white noise and low, indirect lighting. These boxes
measure activity using infrared beam breaks on the x, y, and z
axes. Mice were placed in the center of the field and allowed to
explore freely for 10 minutes. Center time was calculated as the
percent of time spent in the center 25% of the field, and distance
traveled was measured in total cm covered. A total of 797 mice
were phenotyped in the Open Field. Statistics were performed
using Pearson’s r test for correlation (Microsoft Excel). A p-value
test for was conducted for each of the correlation coefficients to
determine the statistical significance of the Pearson’s value. A one-
way ANOVA (JMP, SAS Statistics) was used to calculate
behavioral phenotype differences between haplotypes.
All behavioral data are publicly available under the record
‘‘Pletcher1’’ in the Mouse Phenome Database (http://phenome.
jax.org).
Corticosterone Radioimmunoassay
Trunk blood was collected following live decapitation. All
collections were performed between 1100 h and 1500 h, and
blood was collected within 30 seconds of removing the mice from
the colony room. Blood was allowed to clot on ice, and then serum
was separated out and stored at -80uC. Corticosterone was
measured from 10 ml of serum using a double antibody RIA kit
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detectable level was 0.5 mg/dl, and interassay/intrassay coeffi-
cients of variance were 12.48% and 6.11%, respectively. The RIA
was performed by the Ligand Assay Core at Northwestern
University.
Heritability calculation
For each phenotype, heritability was calculated using 8–16
randomly selected scores from each inbred strain. The number of
scores used for calculating heritability was fixed at the lower level
(8) by the maximum number of scores available for some strains,
and at the upper level (16) by the maximum allowed by the
heritability algorithm. Phenotype values were fit using an ANOVA
model with a single fixed effect (strain), and heritability was
calculated as the adjusted percentage of variance explained. In
order to ensure that estimates were not affected by outliers,
heritability was calculated twice per phenotype using separate
individuals each time. For heritability calculations based on data
downloaded from the Mouse Phenome Database, up to 16 scores
per strain from male mice only were used for each phenotype, and
only the strains used in the present experiment were included in
heritability calculations.
Haplotype mapping
In silico haplotype association mapping was used to link TST
performance to genomic regions with the publicly available
SNPster web tool (http://snpster.gnf.org), which correlates
strain-specific log-transformed phenotype data with a high density
SNP map (roughly 140,000 SNPs or 1 SNP/6 kb) [32,42]. The
SNPster algorithm infers haplotype by use of a sliding 3-SNP
window and calculates an ANOVA F-statistic for each potential
haplotype x phenotype association. The F-statistic is weighted to
reduce the importance of association scores that are largely driven
by closely related strains, such as multiple lines from the C57-
related strains [41]. A generalized family-wise error rate (gFWER)
model is used to set a significance level adjusted for multiple
testing. Standard testing conditions (weight estimate =3, –logP
threshold =2.5, SNP window size =3) were used. For a locus to
be included, it had to have at least 2 haplotypes with at least 5
members each. 1000 genome scans were performed and an F-test
was used to compute significance. gFWER calculations (1000
permutations, k=10) set a raw –logP value of 7 or higher as
significant (adjusted p value ,0.05), and a raw –logP value of 5.65
or higher as suggestive (adjusted p value ,0.1).
SNP genotyping and re-sequencing
SNP genotyping was performed on genomic DNA from the 33
phenotyped inbred mouse strains using a single-base extension
reaction on the Sequenom genotyping platform. In this two-step
process, the region containing the SNP is amplified by PCR, and
then a primer ending at the polymorphic site is used for the single-
base extension reaction. Completed genotyping reactions were
spotted in nanoliter volumes onto a matrix arrayed into 384
elements on a silicon chip (Sequenom SpectroCHIP), and the
allele-specific mass of the extension products was determined by
matrix-assisted laser desorption ionization, time-of-flight mass
spectrometry (MALDI-TOF MS). SPECTROTYPER software
was used for data analysis.
Re-sequencing primers (IDT, Coralville, IA) were designed to
include all translated exon regions for the target genes Socs2, Nudt4,
and Tmem108. Products were amplified from reference genomic
DNA for AKR/J, C57BLKS/J, BTBR T+ tf/J, CBA/J, DBA/2J,
and FVB/NJ, prepared for sequencing using a pre-sequencing 96-
well kit (Millipore, Billerica, MA), and sequenced using a Big Dye
reaction (Applied Biosystems, Foster City, CA) by the University of
Chicago DNA Sequencing Core. Sequence traces were aligned
with and compared to reference sequences from NCBI in order to
identify strain-dependent nucleotide differences.
Results
Behavioral phenotyping
We used the Tail Suspension Test to measure behavioral
despair. To reduce intra-strain variability, only males were used,
and all mice were tested at 7–10 weeks of age. Each strain was
represented by a minimum of 8 and a maximumof 49 individuals,
with an average group size of 25 individuals. In total, 890 mice
were phenotyped, although 110 mice were excluded due to tail-
climbing. As described by other groups using smaller strain sets,
we observed a large, strain-dependent distribution in the duration
of immobility [19] (Figure 1A, Table S2). The time spent
immobile across the final 6 minutes of the 7-minute test ranged
from 6.7% (RIIIS/J) to 59.6% (SM/J). Standard deviation
ranged from 7–17% (average =11%). As noted by previous
groups, several strains had a propensity for tail-climbing during
the test: approximately 35% of C57BL/6J mice, 18% of DBA
mice, and all mice from the two wild-derived strains climbed their
tails, but no tail-climbing was observed in other strains [43]. Mice
that climbed their tails were excluded from analysis; all
subsequent analysis was performed using the 780 successful
measurements.
In the Open Field, as in the TST, there was a clear effect of
strain on both the percent of time spent in the center 25% of the
field (Figure 1B) and distance traveled (Figure 1C, Table S2). All
strains preferred the periphery to the center of the field, but
129S1/SvImJ and A/J were strongly thigmotaxic, while C57BR/
J, MA/MyJ, and NOD/LtJ were much less so. Within-strain SD
was generally lower for % center time than for TST immobility,
averaging only 6% (range 1–16%); however, the overall % center
time range was also lower (0.5–32%).
We observed a strongly significant correlation between distance
traveled and % center time (r=0.75, p,0.0001). In contrast, there
was no correlation between TST immobility and OF thigmotaxis
(r=20.06, p=.75) or between TST immobility and OF distance
traveled (r=0.05, p=0.79). There was also no correlation
between baseline corticosterone and TST immobility (r=0.03,
p=0.87), OF center time (20.10, p=0.59), or OF distance
traveled (20.11, p=0.56).
Heritability
In order to determine the relative contribution of genetics and
environment to the present results, we calculated heritability using
an ANOVA model. For each of the 3 behavioral measures, data
from 14 mice per strain were used. The genetic component was
found to account for an average of 64% of TST immobility across
all strains, 62% of OF distance traveled, and 57% of OF % center
time. By comparison, body weight, which we also measured for
each strain, was 86% heritable.
Haplotype mapping and candidate gene identification
We used haplotype association mapping to identify two genomic
regions that had a gFWER-adjusted p value ,0.05, and an
additional region with an adjusted p-value =0.1 (Table 1,
Figure 2). The first significant region was a 290 kb locus on
MMU10 (-logp =8.17, gFWER-adjusted p value =0.033) that
contained the genes Mrpl2, Ube2n, and Nudt4, and was immediately
adjacent to Socs2. The second significant locus spanned a 300 kb
section of MMU9 (-logP =7.32, gFWER-adjusted p value =
Behavior across Inbred Strains
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the Open Field), and locomotor activity (C, distance traveled in the Open Field). Strain-specific differences were observed for all
phenotypes. Error bars indicate SEM.
doi:10.1371/journal.pone.0014458.g001
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identified several candidate regions that did not meet the stringent
gFWER cutoff but still generated suggestive lod scores with
adjusted p values ,0.2. In order to identify candidate genes, we
genotyped all known SNPs and resequenced the coding regions of
the brain-expressed candidate quantitative genes Tmem108
(NM_178638.3), Socs2 (NM_007706.3), and Nudt4 (NM_027722),
located in or near the two significant TST loci. SNP genotyping
identified two SNPs, one immediately upstream of the Socs2 start
codon, and a second located within the Socs2 exon 2 UTR, that
exhibited the same strain distribution of alleles (A/G) as the
haplotype pattern driving the significant SNPster association on
Figure 2. Haplotype association mapping was used to identify SNPs that associated with TST phenotype. (A) Three SNPs, one on
MMU10 and 2 adjacent SNPs on MMU9, exceeded the significance threshold (gFWER-adjusted p,0.05). Individual SNP logP values are plotted against
cumulative genomic position (bp). P value thresholds are derived from gFWER calculations. (B) Haplotype block pattern at the significant MMU9
locus. Strains are plotted along the x-axis from smallest to largest TST percent immobility; haplotype group is indicated by color/number. All
significant and suggestive loci consisted of a core set of ,5 unrelated, low-immobility strains.
doi:10.1371/journal.pone.0014458.g002
Table 1. Significant or suggestive TST immobility QTLs identified by haplotype mapping.
Chrom Mb -logP p value rsID Candidate Genes
MMU10 94.88–95.17 8.174 0.033 rs6196828 Socs2, Mrpl42, Ube2n, Nudt4
MMU9 103.44–103.74 7.324 0.035 rs29941513 Tmem108
MMU2 145.75–146.97 5.658 0.095 rs3696377 Gm144, Xrn2
MMU9 92.18–92.39 5.302 0.143 rs33747790 Plscr2, Plscr4
doi:10.1371/journal.pone.0014458.t001
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coding regions of any of the genes.
Haplotype mapping of the OF phenotypes returned no
significant loci, although other groups have had success using
inbred mouse strain haplotype mapping to identify loci associated
with locomotor activity and anxiety [44,45].
Discussion
In the present experiments, we phenotyped 33 inbred mouse
strains for immobility in the Tail Suspension Test and anxiety and
activity in the Open Field. We found that these behavioral
measures were consistently highly heritable, strain-specific, and
had a broad phenotypic range similar to what might be expected
in a human population. Our results suggest that performance in
these behavioral tasks should be amenable to genetic dissection.
Behavioral Despair
Although behavioral despair models only one aspect of human
depression, it has both high face validity, as genes that are known
to be involved in human depression affect mouse TST
performance, and high predictive validity for antidepressant
efficacy [8]. Therefore, the identification of genes involved in
the regulation of TST immobility represents a forward genetic
approach to identifying genes that may play a role in human
depression.
We found a very strong effect of strain background on TST
immobility. While other groups have examined TST performance
in up to 12 strains at one time [46,47,48], a number of the strains
we tested have not previously been phenotyped for behavioral
despair. Furthermore, environmental factors (handling, age, sex,
previous behavioral testing) and methods of measurement (manual
versus automated, video tracking versus load displacement) have
been shown to affect performance in behavioral tasks [48,49].
Therefore, we expected some deviation between our raw
immobility scores and previously published reports. While this
was indeed the case, we found that the general strain rank that we
observed is in agreement with results from other labs that have
compared multiple inbred strains. For example, C57BL/6J are
among the most immobile of strains (56% immobility), while A/J
and 129/SvImJ are in the middle of the range (34% and 31%
immobility, respectively) and DBA/2J and BTBR T+ tf/J
represent some of the least immobile strains (16% and 11%
immobility, respectively) [50,51]. We compared our strain
Figure 3. Mouse: human synteny at the MMU10 locus. (A) Ideogram maps of MMU10 and HSA12. The MMU10 locus (in red) is syntenic to a
region on HSA12 (blue) that has been linked to both major depression and bipolar disorder. The brain-expressed gene Socs2 lies within this locus in
both mice and humans. (B) Resequencing identified an A/G polymorphism in the putative promoter region upstream to the Socs2 transcriptional start
site. The ‘‘A’’ allele is carried by the low TST immobility haplotype group, while the ‘‘G’’ allele is found in the haplotype group consisting of higher
immobility strains. (C) The difference in average TST values between the ‘‘A’’ and ‘‘G’’ haplotypes is highly significant (p=5.97
210).
doi:10.1371/journal.pone.0014458.g003
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evaluated C57BL/6J, DBA/2J, A/J, BALB/cJ, C3H/HeJ, NZB/
B1NJ, and CBA/J [50], and Yoshikawa and colleagues, who tested
DBA/2, C3H/He, BALB/c, and C57BL/6 [52], and found that
our immobility scores had a Pearson’s r correlation value of .67
(p=0.05) and .65 (p=0.18), respectively. The correlation between
our TST values and those of Liu and colleagues was lower (r=.50,
p=0.17); however, that group observed a range of only 63–70%
immobility among 6 strains (A/J, SWR/J, FVB/J, BALB/cJ, LP/
J, C3H/HeJ), while in our hands these same strains ranged from
13% (FVB/NJ) to 54% (LP/J) immobility [47]. It should be noted
that no other multi-strain surveys of TST behavior have produced
immobility values similar to the Liu et. al results.
Reverse genetic studies using knockout or knockdown mouse
models have identified a number of genes, primarily genes
involved in monoaminergic neurotransmission and the stress
response axis, that affect TST immobility [8,53]. Other studies
have identified non-synonymous coding SNPs in serotonin
pathway genes, including a SNP in the serotonin transporter
Slc6a4 that regulates serotonin reuptake, and a SNP in Tph2, the
rate-limiting enzyme in brain serotonin synthesis, that affect
antidepressant response [54]. It is possible that a SNP variant in
one of these genes is responsible for some of the strain-specific
TST phenotypes that we observed. To address this possibility, we
looked for an association between SNP variants and TST
immobility for known coding SNPs in Tph2, Slc6a4, all serotonin
receptors, and the genes for corticotrophin releasing hormone (Crh)
and the Crh receptors. The C57BL/6J variant of the Slc6a4 SNP,
which reduces serotonin transport, is found in 2 of the strains we
phenotyped, C57BL/6J and C57BR/J. These strains have fairly
different immobility scores (56% and 30%, respectively), so this
SNP is unlikely to affect baseline immobility. Similarly, A/J,
BALB/cJ, and DBA/2J possess the same Tph2 exon 11 SNP
variant but have very disparate immobility scores, suggesting that
the Tph2 SNP does not have a strong effect on TST immobility.
Several serotonin receptors and Crhr2 also contain non-synony-
mous coding SNPs, but none associate with the strain-dependent
TST immobility scores we observed. Therefore, while complete
deletion of serotonin pathway genes has a clear effect on
behavioral despair, SNP variations within these genes do not
appear to drive the propensity for TST immobility in common
inbred strains.
Open Field behaviors
Overall immobility in the TST is likely to be the sum of a
number of separate behavioral and physiological processes that
include a propensity for learned helplessness, defensive behaviors,
general activity levels, the stress response, and sensory or motor
impairments [8,55]. All of these measures have been shown to vary
between inbred strains. For example, BALB shows a greater
behavioral and physiological response to acute restraint stress than
C57BL/6, and DBA and BALB have higher baseline corticoste-
rone levels than C57BL/6 [23,56]. Additionally, groups such as
Mhyre and colleagues have found significant differences in total
activity and brain neurochemistry among 15 inbred strains [57].
In order to determine the role that the stress response and
general activity levels might play in the expression of TST
behavior, we phenotyped all 33 strains in the Open Field test. In
the OF, overall distance traveled during the test is used as a
measure of general activity, and thigmotaxis (preference for the
wall versus the center) is used as a measure of anxiety that is
responsive to benzodiazepine treatment [58]. There was a clear
effect of strain on both distance traveled and the percent of time
spent in the center 25% of the field. All strains preferred the
periphery to the center of the field, but certain strains did so much
more strongly. As with the TST, raw strain % center time values
differed, but strain rank was consistent with previously published
studies. Bothe and colleagues evaluated 14 inbred strains in the
OFT and found the 129 and A/J strains to be least active and
most thigmotaxic, and NOD to be most active [59]; Bolivar and
colleagues observed a similar aversion for the center in 129 and A/
J strains [60]. Using a different measure of anxiety, the elevated
plus maze, Wahlsten and colleagues found that A/J was much less
active than four other inbred strains [61]. These results are
consistent with our data.
We compared our OF and TST scores to determine whether
there was overlap in the phenotypes being evaluated. There was
no significant correlation between TST immobility and either
center preference or distance traveled in the OF. We also found no
correlation of baseline corticosterone levels between performance
in either the TST or OF. These results suggest that, under baseline
conditions, the genetic factors underlying TST performance are
likely to be somewhat distinct from those regulating motor activity,
general anxiety, and the stress response. This does not, however,
invalidate the many reports that have identified an association
between stress and depression in humans, or between chronic
stress and behavioral despair in animal models [16,62]. It is
important to note that the behaviors reported here were measured
in animals that were not genetically, behaviorally, or chemically
manipulated to have an increased propensity for stress or anxiety,
which may affect associations between the two phenotypes.
Heritability
The ability to accurately associate behavioral phenotypes with
genotype depends on the degree to which the behavior is
genetically determined. Although the ANOVA calculation used
here measures heritability in a broad, rather than gene-specific,
manner, the results suggest that TST and OF behaviors have a
strong genetic component. We used the same genetic component
calculation to determine the heritability of several inbred strain
phenotypes available in the Mouse Phenome Database. Some
physiological measures, including HDL cholesterol level [63], red
blood cell number [64], and daily food intake [65], were under
stronger genetic regulation than our behavioral measures, but a
surprising number were not, including blood glucose [66] and
percent body fat [67]. The heritability observed in our TST and
OF data was often significantly higher than that of other
behavioral measures in the MPD. For example, pre-pulse
inhibition [68] and daily activity [65] were only 37% and 51%
heritable, respectively. This analysis suggests that environment has
a minimal effect on the variance observed, meaning that the
phenotypes observed in the TST and OF should be highly
amenable to genetic dissection.
A number of researchers have noted the effect of environment
and handling on behavioral performance [61,69]. One group
found that environmental factors accounted for significantly more
variance in a nociceptive response than genetic factors (42% and
27%, respectively) [69]. Another group measured multiple
behaviors, including performance in the open field, plus maze,
and water maze, in 8 inbred strains in 3 separate labs; despite
careful standardization of housing, care, and testing procedures,
the testing environment was often more influential than genetic
background [49]. These results have clear implications for any
experiment that seeks to use behavioral differences among strains
as a phenotype for QTL analysis. We attempted to minimize
environmental factors by standardizing housing density, handlers
and handling procedures, and post-shipment recovery time. We
phenotyped mice from the same strains multiple times over the
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behavior: for example, the first group of DBA/2J mice phenotyped
had an average immobility of 13%, while the most recently
phenotyped DBA/2J mice, tested up to 19 months after the first
set, averaged 14.8% immobility. These data suggest that our
procedures were effective at reducing within-lab variability.
Additionally, the significant correlation of rank placement of
strains in the behavioral tests in our lab with previously published
results indicates that the behaviors we observed are fairly resistant
to environmental effects [8,59].
Haplotype mapping and candidate gene identification
Genome-wide analyses of the genetic polymorphisms underly-
ing complex behavioral traits have not historically been successful
at identifying causative genes. In humans, family linkage studies
have low statistical power and can usually only identify Mendelian
traits; in mice, QTL studies using F2 or recombinant inbred (RI)
crosses have poor genetic resolution, with an average locus size
greater than 20 Mb [70]. Five groups have used traditional QTL
analysis to identify loci involved in the regulation of behavioral
despair in mice. Yoshikawa and colleagues used an F2 intercross of
the C57BL/6 and C3H/He strains to identify TST- and FST-
associated loci on MMU4 and MMU11 [52]. Liu and colleagues,
using an F2 cross of the NMRI and 129S6 strains, identified 3
significant baseline TST loci on MMU5, MMU12, and MMU18
[71]. More recently, Lad and colleagues used 24 BXD
recombinant inbred strains to identify candidate loci on MMU4
and MMU15 [48]. TST performance has also been measured in
the DeFries High and Low mice, lines selectively bred for high or
low anxiety from an F2 cross of BALB/c and C57BL/6. This
mapping effort identified four significant loci on MMU3, MMU5,
MMU11, and MMU19 [72]. Notably, of almost twenty TST-
associated QTLs that have previously been identified, only one, on
MMU4, has been replicated in a second study, and only two
groups have validated candidate genes [73,74].
Alternatively, haplotype association mapping has the potential
to identify novel quantitative trait genes and pathways with high
genetic resolution. Although this approach has been successfully
utilized to identify biologically relevant genes that underlie
complex, multigenic phenotypes, there are concerns associated
with the technique. Primarily, it has been suggested that a limited
strain set combined with redundant population substructures
across the genome will result in an unreasonably high false positive
rate [75,76]. Therefore, significant follow-up validation is required
of findings resulting from HAM analysis in order to provide the
absolute proof of the validity of the genotype/phenotype
relationship. However, the multiple published validations of the
HAM methodology indicate there is value in running the
computationally cheap and relatively quick analysis as means to
gain potential insights into the behavior genetics at play in this
combination of inbred strains.
In the present experiment, we identified two loci of ,300 kb
each with a lod score .7 and a genome-wide FWER-adjusted p
value ,0.05. Several other loci with suggestive p values (lod .5.0,
p,0.20) were also identified (Figure 2A). Each of these regions
contains a limited number of brain-expressed genes that may
regulate performance in the TST. For all regions, the most
significant haplotype x phenotype associations were driven by an
inferred haplotype pattern that always included the low-immobil-
ity strains LG/J and MRL/MpJ and also included at least two or
more of five other low-immobility strains (NZO/H1LtJ, RIIIS/J,
BTBR tf/J, FVB/NJ, and DBA/2J), while typically excluding
every other strain (Figure 2B). Genealogical trees created from
microsatellite and SNP data indicate that these 7 strains represent
at least 5 of the separate ancestral lineages described by Beck and
colleagues [77]. Such divergent ancestry suggests that the
association of these strains is not spurious, and instead represents
true phenotype/genotype associations.
The significant locus on MMU10 is syntenic to a region on
human chromosome (HSA) 12 (Figure 3A). HSA12q23, is one of a
very few loci to be associated with major depressive disorder
(MDD) and bipolar disorder (BPD) in multiple experimental
cohorts, including 497 European and American sibling pairs
(recurrent depression) [78], 1,890 individuals from 110 Mormon
pedigrees (major depression) [79], and a small European pedigree
affected by both Darier’s disease and bipolar disorder [80]. Only
two candidates near or within this locus are expressed in the brain:
Socs2, which is involved in neurogenesis, and Nudt4/Dipp2, which
regulates phosphatase signaling in the brain. In order to indentify
candidate quantitative phenotype genes, we resequenced the Socs2
and Nudt4 coding regions and genotyped SNPs within the
MMU10 locus (Figure 3B). Although we did not identify any
gene expression or coding changes that co-segregated with TST
performance, we found 2 SNPs near or within Socs2 that, unlike all
surrounding SNPs, exhibited the same strain distribution of alleles
(A/G) as the haplotype pattern driving the significant SNPster
association on MMU10 (Figure 3C). Socs2 has been shown to
promote neurogenesis and enhance neurite outgrowth, a function
relevant to depression: hippocampal volume is often reduced in
depressed patients [81], and antidepressants may alleviate
depression by promoting neurogenesis [82].
Although we found no coding SNPs in the Socs2 genomic
sequence and no haplotype group-associated gene expression
differences, it is possible that the noncoding SNPs that we
identified affect multiple other functions, including protein
conformation and stability, mRNA stability, promoter element
binding frequency, and miRNA binding [83]. In a recent study,
Cyp2c29 was identified as the most likely candidate for inter-strain
differences in warfarin metabolism by haplotype association
mapping, but no strain-specific polymorphisms were identified in
the coding region of the gene and no differences in gene expression
were observed [84]. Therefore, non-coding SNPs are capable of
affecting protein expression or function without necessarily
altering mRNA expression.
Recent large-scale strain studies have shown that inbred mouse
strains represent a diversity of physiological phenotypes similar to
those found in human populations [21,85]. The present results
extend this observation to the behavioral realm, and suggest that
inbred mouse strains will be a valuable resource for modeling the
variability of human behavioral traits. Furthermore, the availabil-
ity of phenotyping data for such a large number of strains can be
used to inform strain selection for F2 mapping crosses, and may
also be useful for identifying appropriate strains for testing
behavior-modifying drugs.
Supporting Information
Table S1 Strains phenotyped for behavioral and physiological
characteristics - Average body weight and baseline corticosterone
levels (mg/dl) are provided.
Found at: doi:10.1371/journal.pone.0014458.s001 (0.02 MB
XLS)
Table S2 Average results for TST immobility, OF center time,
and OF distance traveled - Complete data are available under the
file Pletcher1 in the Mouse Phenome Database.
Found at: doi:10.1371/journal.pone.0014458.s002 (0.03 MB
XLS)
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